Skip to content

Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications

Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02094118
Enrollment
171
Registered
2014-03-21
Start date
2016-01-31
Completion date
2019-05-30
Last updated
2021-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Transfusion Complications

Keywords

Transfusion, RBC, cardiac, surgery, transfusion related acute lung injury (TRALI), transfusion associated circulatory overload (TACO)

Brief summary

This study is designed to determine if point-of-care washing of allogeneic Leukocyte-Reduced Red Blood Cells reduces pulmonary complications when compared to standard-of-care Leukocyte-Reduced Red Blood Cells in a cardiac surgical population.

Interventions

BIOLOGICALPoint-of-care washed red blood cell transfusion.
BIOLOGICALStandard of care red blood cell transfusion.

Sponsors

Duke University
CollaboratorOTHER
Vitalant Research Institute
CollaboratorOTHER
Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age equal to or greater than 18 years of age. * Scheduled to have cardiac bypass surgery at Mayo Clinic in Rochester, Minnesota or Duke University Medical Center in Durham, North Carolina * At risk for needing at least 4 units of blood during/after surgery

Exclusion criteria

* Emergency surgery * Immunoglobulin A (IgA) deficiency * History of severe recurrent transfusion reactions * Refusal to receive allogeneic blood products * Refusal to provide informed consent * Prevalent lung injury prior to randomization * Prevalent congestive heart failure prior to randomization * Expected hospital stay \< 48 hours * Not anticipated to survive \> 48 hours * Previously enrolled in this trial * No plan for placement of a pulmonary artery catheter * Use of home oxygen therapy * Complex RBC antibody profiles * Need for the use of irradiated RBCs

Design outcomes

Primary

MeasureTime frameDescription
Change in HaptoglobinPre transfusion to study day 5 or hospital discharge, approximately 5 daysChange in Haptoglobin from pre-transfusion to worst (minimum) post-transfusion
Biomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.18 hours after the initiation of the first red blood cell transfusion.This panel of biomarkers measures inflammation, altered coagulation, and endothelial activation all of which play key roles in the pathogenesis of lung injury.
Number of Off-protocol TransfusionsDay of surgery. Approximately 1 day.The number of standard issued red blood cell units that were transfused to study participants in the washed red blood cell arm of the trial. Additionally, emergency red blood cell transfusions in the standard issued arm of the trial that were administered outside of the study protocol were also included to the definition of off protocol transfusion.
Change in Recipient HemoglobinPre to 6 hours post transfusionChange in Hemoglobin from pre-transfusion to post-transfusion
Change in Recipient Cell Free Hemoglobin(CFH)Pre transfusion until study day 5 or hospital discharge, approximately 5 daysChange in CFH from pre-transfusion to worst (highest/maximum) post-transfusion

Secondary

MeasureTime frameDescription
Duration of Mechanical VentilationUp to hospital day 28, or discharge, whichever comes firstNumber of hours subject received mechanical ventilation.
Duration of Oxygen SupplementationUp to day 28, or hospital discharge, whichever comes firstNumber of hours subjects received supplemental oxygen.
Sequential Organ Failure Assessment (SOFA) ScoreThrough postoperative day 5.Worst SOFA score between Day 1 and Day 5. SOFA scores range from 0-24 with 0 meaning no organ dysfunction and 24 means severe dysfunction of all organ systems evaluated. Each of 6 organ systems are scored on a 0-4 scale with the cumulative score being the total SOFA score.
Hospital Length of StayUp to day 28Number of days subject remained in the hospital following their surgical procedure. If the number of days the subject remained in the hospital exceeded 28, a value of 28 is assigned.
Post Transfusion Respiratory Complications.Up to day 28Development of transfusion-related lung injury (TRALI) or transfusion-associated circulatory overload (TACO).

Countries

United States

Participant flow

Participants by arm

ArmCount
Standard of Care Red Blood Cell Transfusion
Red blood cells that are administered in the normal fashion. Standard of care red blood cell transfusion.
85
Point-of-Care Washed Red Blood Cell Transfusion
Red blood cells that are washed at the point-of-care. Point-of-care washed red blood cell transfusion.
86
Total171

Baseline characteristics

CharacteristicStandard of Care Red Blood Cell TransfusionTotalPoint-of-Care Washed Red Blood Cell Transfusion
Age, Continuous66.1 years
STANDARD_DEVIATION 11.4
65.6 years
STANDARD_DEVIATION 11.7
65.0 years
STANDARD_DEVIATION 12.1
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants6 Participants5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
81 Participants159 Participants78 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
3 Participants6 Participants3 Participants
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants2 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants4 Participants3 Participants
Race (NIH/OMB)
Black or African American
14 Participants29 Participants15 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants6 Participants4 Participants
Race (NIH/OMB)
White
66 Participants130 Participants64 Participants
Region of Enrollment
United States
85 participants171 participants86 participants
Sex: Female, Male
Female
43 Participants84 Participants41 Participants
Sex: Female, Male
Male
42 Participants87 Participants45 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
2 / 853 / 86
other
Total, other adverse events
0 / 850 / 86
serious
Total, serious adverse events
0 / 857 / 86

Outcome results

Primary

Biomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.

This panel of biomarkers measures inflammation, altered coagulation, and endothelial activation all of which play key roles in the pathogenesis of lung injury.

Time frame: 18 hours after the initiation of the first red blood cell transfusion.

Population: Patients undergoing cardiac surgery who were predicted to be at high risk for requiring red blood cell transfusion.

ArmMeasureGroupValue (MEDIAN)
Standard of Care Red Blood Cell TransfusionBiomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.IL-812 units on a scale (pg/ml)
Standard of Care Red Blood Cell TransfusionBiomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.vWF107 units on a scale (pg/ml)
Standard of Care Red Blood Cell TransfusionBiomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.RAGE3262 units on a scale (pg/ml)
Standard of Care Red Blood Cell TransfusionBiomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.SP_D7238 units on a scale (pg/ml)
Standard of Care Red Blood Cell TransfusionBiomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.PAI_173418 units on a scale (pg/ml)
Standard of Care Red Blood Cell TransfusionBiomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.ICAM_1404914 units on a scale (pg/ml)
Standard of Care Red Blood Cell TransfusionBiomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.IL-6101 units on a scale (pg/ml)
Point-of-Care Washed Red Blood Cell TransfusionBiomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.PAI_153829 units on a scale (pg/ml)
Point-of-Care Washed Red Blood Cell TransfusionBiomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.IL-6105 units on a scale (pg/ml)
Point-of-Care Washed Red Blood Cell TransfusionBiomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.IL-815 units on a scale (pg/ml)
Point-of-Care Washed Red Blood Cell TransfusionBiomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.SP_D7061 units on a scale (pg/ml)
Point-of-Care Washed Red Blood Cell TransfusionBiomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.vWF111 units on a scale (pg/ml)
Point-of-Care Washed Red Blood Cell TransfusionBiomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.ICAM_1404129 units on a scale (pg/ml)
Point-of-Care Washed Red Blood Cell TransfusionBiomarkers Associated With Transfusion-Related Acute Lung Injury and Transfusion Associated Circulatory Overload.RAGE4516 units on a scale (pg/ml)
Primary

Change in Haptoglobin

Change in Haptoglobin from pre-transfusion to worst (minimum) post-transfusion

Time frame: Pre transfusion to study day 5 or hospital discharge, approximately 5 days

ArmMeasureValue (MEDIAN)
Standard of Care Red Blood Cell TransfusionChange in Haptoglobin-48.5 units on a scale (mg/dl)
Point-of-Care Washed Red Blood Cell TransfusionChange in Haptoglobin-54 units on a scale (mg/dl)
Primary

Change in Recipient Cell Free Hemoglobin(CFH)

Change in CFH from pre-transfusion to worst (highest/maximum) post-transfusion

Time frame: Pre transfusion until study day 5 or hospital discharge, approximately 5 days

ArmMeasureValue (MEDIAN)
Standard of Care Red Blood Cell TransfusionChange in Recipient Cell Free Hemoglobin(CFH)22.8 units on a scale (mg/dl)
Point-of-Care Washed Red Blood Cell TransfusionChange in Recipient Cell Free Hemoglobin(CFH)23 units on a scale (mg/dl)
Primary

Change in Recipient Hemoglobin

Change in Hemoglobin from pre-transfusion to post-transfusion

Time frame: Pre to 6 hours post transfusion

ArmMeasureValue (MEDIAN)
Standard of Care Red Blood Cell TransfusionChange in Recipient Hemoglobin2.6 units on a scale (g/dl)
Point-of-Care Washed Red Blood Cell TransfusionChange in Recipient Hemoglobin2.3 units on a scale (g/dl)
Primary

Number of Off-protocol Transfusions

The number of standard issued red blood cell units that were transfused to study participants in the washed red blood cell arm of the trial. Additionally, emergency red blood cell transfusions in the standard issued arm of the trial that were administered outside of the study protocol were also included to the definition of off protocol transfusion.

Time frame: Day of surgery. Approximately 1 day.

ArmMeasureValue (NUMBER)
Standard of Care Red Blood Cell TransfusionNumber of Off-protocol Transfusions3 transfusions
Point-of-Care Washed Red Blood Cell TransfusionNumber of Off-protocol Transfusions22 transfusions
Secondary

Duration of Mechanical Ventilation

Number of hours subject received mechanical ventilation.

Time frame: Up to hospital day 28, or discharge, whichever comes first

ArmMeasureValue (MEDIAN)
Standard of Care Red Blood Cell TransfusionDuration of Mechanical Ventilation10.3 units on a scale (hours)
Point-of-Care Washed Red Blood Cell TransfusionDuration of Mechanical Ventilation10.8 units on a scale (hours)
Secondary

Duration of Oxygen Supplementation

Number of hours subjects received supplemental oxygen.

Time frame: Up to day 28, or hospital discharge, whichever comes first

ArmMeasureValue (MEDIAN)
Standard of Care Red Blood Cell TransfusionDuration of Oxygen Supplementation84.7 units on a scale (hours)
Point-of-Care Washed Red Blood Cell TransfusionDuration of Oxygen Supplementation89.5 units on a scale (hours)
Secondary

Hospital Length of Stay

Number of days subject remained in the hospital following their surgical procedure. If the number of days the subject remained in the hospital exceeded 28, a value of 28 is assigned.

Time frame: Up to day 28

ArmMeasureValue (MEDIAN)
Standard of Care Red Blood Cell TransfusionHospital Length of Stay12 units on a scale (days)
Point-of-Care Washed Red Blood Cell TransfusionHospital Length of Stay12 units on a scale (days)
Secondary

Post Transfusion Respiratory Complications.

Development of transfusion-related lung injury (TRALI) or transfusion-associated circulatory overload (TACO).

Time frame: Up to day 28

ArmMeasureGroupValue (NUMBER)
Standard of Care Red Blood Cell TransfusionPost Transfusion Respiratory Complications.TACO7 participants
Standard of Care Red Blood Cell TransfusionPost Transfusion Respiratory Complications.TRALI1 participants
Point-of-Care Washed Red Blood Cell TransfusionPost Transfusion Respiratory Complications.TACO5 participants
Point-of-Care Washed Red Blood Cell TransfusionPost Transfusion Respiratory Complications.TRALI0 participants
Secondary

Sequential Organ Failure Assessment (SOFA) Score

Worst SOFA score between Day 1 and Day 5. SOFA scores range from 0-24 with 0 meaning no organ dysfunction and 24 means severe dysfunction of all organ systems evaluated. Each of 6 organ systems are scored on a 0-4 scale with the cumulative score being the total SOFA score.

Time frame: Through postoperative day 5.

ArmMeasureValue (MEDIAN)
Standard of Care Red Blood Cell TransfusionSequential Organ Failure Assessment (SOFA) Score12 units on a scale
Point-of-Care Washed Red Blood Cell TransfusionSequential Organ Failure Assessment (SOFA) Score13 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026